FR2781220B1 - Piperazinones substituees en beta - Google Patents

Piperazinones substituees en beta

Info

Publication number
FR2781220B1
FR2781220B1 FR9809168A FR9809168A FR2781220B1 FR 2781220 B1 FR2781220 B1 FR 2781220B1 FR 9809168 A FR9809168 A FR 9809168A FR 9809168 A FR9809168 A FR 9809168A FR 2781220 B1 FR2781220 B1 FR 2781220B1
Authority
FR
France
Prior art keywords
piperazinones
substituted beta
beta
substituted
beta piperazinones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9809168A
Other languages
English (en)
Other versions
FR2781220A1 (fr
Inventor
Christophe Yue
Marguerite Henry
Thierry Giboulot
Brigitte Lesur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9809168A priority Critical patent/FR2781220B1/fr
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to EP99929496A priority patent/EP1098888A1/fr
Priority to JP2000560107A priority patent/JP2002520401A/ja
Priority to US09/743,411 priority patent/US6344456B1/en
Priority to CNB998087033A priority patent/CN1188402C/zh
Priority to NZ509166A priority patent/NZ509166A/en
Priority to AU46291/99A priority patent/AU752632B2/en
Priority to BR9912839-0A priority patent/BR9912839A/pt
Priority to PCT/FR1999/001747 priority patent/WO2000004000A1/fr
Priority to EA200100151A priority patent/EA003511B1/ru
Priority to CA002337849A priority patent/CA2337849C/fr
Publication of FR2781220A1 publication Critical patent/FR2781220A1/fr
Application granted granted Critical
Publication of FR2781220B1 publication Critical patent/FR2781220B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9809168A 1998-07-17 1998-07-17 Piperazinones substituees en beta Expired - Fee Related FR2781220B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR9809168A FR2781220B1 (fr) 1998-07-17 1998-07-17 Piperazinones substituees en beta
PCT/FR1999/001747 WO2000004000A1 (fr) 1998-07-17 1999-07-16 Derives de piperazinones et leurs applications
US09/743,411 US6344456B1 (en) 1998-07-17 1999-07-16 Piperazinone derivatives and their uses
CNB998087033A CN1188402C (zh) 1998-07-17 1999-07-16 哌嗪酮衍生物及其应用
NZ509166A NZ509166A (en) 1998-07-17 1999-07-16 Piperazinone derivatives useful as antithrombotic agents
AU46291/99A AU752632B2 (en) 1998-07-17 1999-07-16 Piperazinone derivatives and their uses
EP99929496A EP1098888A1 (fr) 1998-07-17 1999-07-16 Derives de piperazinones et leurs applications
JP2000560107A JP2002520401A (ja) 1998-07-17 1999-07-16 ピペラジノン誘導体及びその利用
EA200100151A EA003511B1 (ru) 1998-07-17 1999-07-16 Производные пиперазинона и их применение
CA002337849A CA2337849C (fr) 1998-07-17 1999-07-16 Derives de piperazinones et leurs applications
BR9912839-0A BR9912839A (pt) 1998-07-17 1999-07-16 Derivados de piperazinomas e suas aplicações

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9809168A FR2781220B1 (fr) 1998-07-17 1998-07-17 Piperazinones substituees en beta

Publications (2)

Publication Number Publication Date
FR2781220A1 FR2781220A1 (fr) 2000-01-21
FR2781220B1 true FR2781220B1 (fr) 2000-10-13

Family

ID=9528734

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9809168A Expired - Fee Related FR2781220B1 (fr) 1998-07-17 1998-07-17 Piperazinones substituees en beta

Country Status (11)

Country Link
US (1) US6344456B1 (fr)
EP (1) EP1098888A1 (fr)
JP (1) JP2002520401A (fr)
CN (1) CN1188402C (fr)
AU (1) AU752632B2 (fr)
BR (1) BR9912839A (fr)
CA (1) CA2337849C (fr)
EA (1) EA003511B1 (fr)
FR (1) FR2781220B1 (fr)
NZ (1) NZ509166A (fr)
WO (1) WO2000004000A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200401335A1 (ru) * 2002-04-08 2006-02-24 Ранбакси Лабораторис Лимитед Производные карбоксимида в качестве уроселективных блокаторов альфа-1a адренорецепторов
US20060247249A1 (en) * 2005-11-16 2006-11-02 Mohammad Salman Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers
KR100967171B1 (ko) 2007-12-26 2010-07-05 재단법인서울대학교산학협력재단 Δ5-2-옥소피페라진 유도체 및 그의 고체상 합성 방법
US20140205566A1 (en) 2012-11-30 2014-07-24 Novartis Ag Cyclic nucleuoside derivatives and uses thereof
CN106860480A (zh) * 2017-02-13 2017-06-20 武汉贝纳科技服务有限公司 一种血小板及含有血小板的制剂的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4234295A1 (de) * 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4302485A1 (de) * 1993-01-29 1994-08-04 Merck Patent Gmbh Piperazinderivate

Also Published As

Publication number Publication date
NZ509166A (en) 2004-01-30
CA2337849C (fr) 2009-03-17
JP2002520401A (ja) 2002-07-09
WO2000004000A1 (fr) 2000-01-27
CA2337849A1 (fr) 2000-01-27
AU4629199A (en) 2000-02-07
FR2781220A1 (fr) 2000-01-21
AU752632B2 (en) 2002-09-26
EA003511B1 (ru) 2003-06-26
US6344456B1 (en) 2002-02-05
CN1309648A (zh) 2001-08-22
CN1188402C (zh) 2005-02-09
EA200100151A1 (ru) 2001-06-25
BR9912839A (pt) 2001-06-05
EP1098888A1 (fr) 2001-05-16

Similar Documents

Publication Publication Date Title
NO20006268L (no) <Beta>karbolinforbindelser
ATE341990T1 (de) Sigmidoskop
IS5807A (is) Þíóbensimídasólafleiður
DE69934788D1 (de) Biozide benzylbiphenylderivative
DE59901560D1 (de) Retrograder tibianagel
NO990511D0 (no) Sidebr°nn-tilkopling
ID23761A (id) Trisiklik tersubstitusi
DE69902762D1 (de) Riser-spannanordnung
ID24221A (id) Tempat patrum
ATE262513T1 (de) Benzoylpyridazine
ID23219A (id) Trisiklik tersubstitusi
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59807217D1 (de) Nadellager
DE59808995D1 (de) Endomikroskopsystem
DE19842103B4 (de) Stanznietzuführung
FI980759A0 (fi) Taetningskonstruktion foer suglaodan i en sugvals
FR2781220B1 (fr) Piperazinones substituees en beta
FR2781221B1 (fr) Piperazinones substituees en alpha
DE59911393D1 (de) Ausdrehkopf
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
DE59912532D1 (de) Substituierte acylaminophenyl-uracile
DE59912188D1 (de) Substituierte phenyluracile
DE59911610D1 (de) Substituierte benzoylcyclohexandione
FI980856A0 (fi) Andningsskydd utrustad med en identifierare
NO980270L (no) Trekkanordning

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100331